title: Percutaneous local therapies for hepatocellular carcinoma impair gastric function.
authors.forename: Fumihiko
authors.initials: F
authors.lastname: Kinekawa
authors.forename: Kazuya
authors.initials: K
authors.lastname: Matsuda
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Masaki
authors.forename: Kazutaka
authors.initials: K
authors.lastname: Kurokohchi
authors.forename: Hirohito
authors.initials: H
authors.lastname: Yoneyama
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Inoue
authors.forename: Hirohide
authors.initials: H
authors.lastname: Kurata
authors.forename: Yoshihito
authors.initials: Y
authors.lastname: Uchida
authors.forename: Seishiro
authors.initials: S
authors.lastname: Watanabe
authors.forename: Shigeki
authors.initials: S
authors.lastname: Kuriyama
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D006528:Carcinoma, Hepatocellular / Q000503:physiopathology / Q000628:therapy*; D017115:Catheter Ablation; D000431:Ethanol / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D008113:Liver Neoplasms / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D013270:Stomach / Q000503:physiopathology*
chemical_list: D000431:Ethanol